a reductionistic approach that seeks "to understand the whole through the parts" (ie "functional anatomy," if we talk about a biological structure) can be exceptionally efficient: through analysis of cell kinetics and morphological changes in distinct HF anatomical parts, this approach would help to understand the basic principles of HF functioning in its entirety. And modern state-of-the-art methodologies, like lineage tracing [1, 2] or in vivo imaging, [3, 4] are providing effective tools for this endeavour.
One of the most interesting and peculiar objects for such studies is the secondary hair germ (SHG)-a transitory structure in the lower mouse telogen HF ( Figure 1 ). Despite its provisional nature, the SHG appears to be a key player in anagen induction and HF regrowth.
Therefore, the insight into SHG functions and its ontogenetic relations with other HF parts represents one of the key objectives of hair biology. During the last two decades, the SHG has been under attention of hair and stem cell researchers, yet many aspects of its functioning remain unclear or a subject of controversy.
The SHG was identified as a distinct morphological entity and as a cellular source of mouse anagen HF regrowth nearly a hundred years ago. [5] However, because the skin stem cell concept was not yet on the agenda at that time, SHG was mostly disregarded, especially given its transitory nature. In 1990, the bulge activation hypothesis was put forth designating the bulge as a reservoir of HF stem cells and a direct target for follicular papilla (FP) anageninducing signalling. [6] Therefore, the bulge was assumed a driver of anagen HF regrowth. This elegant concept gave a strong impulse to hair research, but, at the same time, overshadowed the role of the SHG in anagen initiation and in maintenance of mouse HF regrowth potential. In subsequent publications, SHG was often ignored or considered just as a part of the bulge despite the data on its leading role in telogen-anagen transition continued to accumulate (eg [7] ).
The lack of understanding of SHG-bulge relations further limited the interest towards this part of mouse HF.
In 2001, a hypothesis of HF predetermination was proposed, [8] which not only reiterated the chief role of the SHG in anagen initiation, [5] but also suggested that SHG cells are specifically destined to form highly specialized ascending layers of the HF, while the role of the bulge was reduced to production of non-specialized cells of the outer root sheath (ORS). It was also suggested that the SHG does not originate directly from the bulge, but rather from its ORS descendants, which survive destruction of lower (cycling) HF part during the catagen stage of the HF cycle and move upward together with the shrinking epithelial strand ( Figure S1 ).
Therefore, at the core of this hypothesis was the idea that physical partitioning of SHG cells (or their precursors) from the bulge and their intimate contact with the FP "instruct" or "predetermine" the SHG for a very specific role-to be a principal cellular source for a "morphogenetic burst" resulting in formation of an exceptionally complex ascending compartment of the HF. Thus, the SHG was brought back into relevance, especially in light of growing interest in HF stem cell kinetics. During recent years, a number of studies have been published addressing the role of SHG in anagen induction, in maintenance of the HF stem cell niche and in restoration of HF structure after its damage [eg [9] [10] [11] [12] [13] ]. Nevertheless, so far, there has been only one systemic attempt to elucidate the structural, functional and expressional nature of this cell population. [14] Some crucial aspects of SHG biology remain undefined. [8] ). The HF consists of a permanent (upper) portion and a cycling lower portion that undergoes cycles of destruction and restoration (see drawing for Anagen IV). The stages of HF regression (catagen) and growth (anagen) are separated by the "resting" phase-telogen. The induction of anagen is associated with a burst of proliferation in the lower portion of the telogen follicle. In early anagen, the epithelial portion of the HF grows downward and completely engulfs the FP, which also undergoes substantial structural changes. At this point, the prominent upward flow of epithelial cells is formed; these originate from the hair matrix (from its germinative layer, bordering the FP), where active proliferation takes place. Proliferation of hair matrix cells results in the formation of the hair shaft (comprising medulla, cortex and hair cuticle) and inner root sheath (IRS; comprising cuticle, Huxley's and Henle's layers). The ascending HF layers are encased by the outer root sheath (ORS). The epithelial compartment of the anagen HF (hair shaft, IRS, ORS) is surrounded by the dermal sheath, a structure of mesenchymal origin that is contiguous with the FP. Anagen HFs (depending on their functional type) are associated with complex vascular and neural networks. Anagen lasts approximately two weeks in mice and up to 4-5 y in humans.
With the transition to catagen, the lower HF portion undergoes apoptosis-driven diminution, and the hair bulb shrinks. The FP condenses and travels upward along with the regressing lower epithelial portion-the epithelial strand. It comes into direct contact the lower part of the overlying permanent portion of the HF. Interdigitation and specific patterns of keratinization of the hair shaft cells and cells of the ORS form the club hair, which anchors the hair shaft in the follicle their potential and fate or are they all the same? What is the exact pattern of SHG cell rearrangements during early anagen? Some of these issues are the subject of this review.
| THE S ECONDARY HAIR G ERM IS A D IS TIN C T S TRUC TURE IN THE MOUS E HF

| Morphology of the secondary hair germ
In mouse skin, the SHG is formed in late catagen [5] -just before the formation of club hair and transition of the follicle into the "dormant" telogen stage of the cycle ( Figure 1 ). 1 With the beginning of anagen, entire SHG cell population is involved in new HF growth.
Thus, the SHG is a transient structure associated exclusively with telogen. In fact, together with the club hair, the SHG represents a structural hallmark of this "resting" stage of the murine HF cycle.
The term "secondary" in designation of this structure is used to distinguish it from the "primary" hair germ-a HF primordium in embryonic/perinatal mammalian skin associated with the epidermis.
Morphologically, the SHG is a compact cluster of cells situated between the FP and the lower part of the telogen HF which engulfs the club hair and represents "the bulge" (Figure 1 and 2A). Therefore, 1 For details on HF cycling, see [15] for mouse and [16] for human skin. D-E, (adopted with permission from Lorz et al., 2010 [152] ): CD34
and Keratin 15 expression in the telogen mouse HF. D, CD34 is localized exclusively to the bulge of mouse HF. E, K15 expression is seen not only in the bulge, but also in the SHG. Cells of lower SHG (adjacent to FP) are K15-poor or-negative (block arrowhead). F-G, (adopted with permission from Müller-Röver et al., 1999 [32] ): P-cad expression in mouse telogen and early anagen pelage follicles. F, Telogen hair follicle: strong P-cad IR on keratinocytes of the lower SHG (small arrow); weak or virtually no P-cad IR on keratinocytes of the ORS (arrowhead) and the epidermis (large arrow). G, Early anagen hair follicle (day 3 after depilation): strong P-cad IR on keratinocytes of the developing hair matrix (white arrow; lower SHG progeny); weak P-cad IR on keratinocytes of the ORS (arrowhead; upper SHG progeny) and no P-cad IR on epidermal keratinocytes (large arrow). H, (adopted with permission from Greco et al., 2009 [14] ): Bulge-derived LRC is also present in the upper SHG (white the SHG is the only epithelial part of the follicle that is in direct contact with the FP during the telogen and telogen-anagen transition. In this light, the common belief that communication between the FP and bulge-located stem cells drives the impending anagen appears to be incorrect-the FP and the bulge are not in direct communication, as they are separated by the SHG. The area of FP-SHG contact is substantial: the SHG usually has a concave bottom and the FP is partially impressed into it or vice versa ( Figure 2A,F,H) . This extensive contact between the FP and SHG during telogen certainly has an adhesive role, keeping the FP in place under severe mechanical stress in the upper skin layers. This intimate association undoubtedly has a communicative significance as well. [17, 18] The basement membrane that separates the epithelial cells of the SHG and mesenchymal cells of the FP is relatively thick and multilayered ( Figure 3E ). Nevertheless, it is penetrable to regulatory molecules of different kinds. [19] In contrast with the expansive SHG-FP boundary, the epithelial "neck" connecting the SHG and the bulge is usually narrow, and often further strangulated by a deep groove (Figure 2A,F and 4A) which disappears at anagen onset due to cell proliferation at the SHG/bulge border. This groove may lessen the bulge-germ communication in telogen, thus adding to preservation of bulge cells from "unwanted" signalling influence from below. It may also protect the germ in case of forced extraction of the shaft: it is known that depilation during telogen phase of the cycle results in complete obliteration of the bulge, while the SHG is usually spared [20] acquiring the ability to reconstitute the bulge and entire HF structure. [21] In telogen (excluding its terminal, pre-anagen phase), the SHG is composed of quiescent cells with minimal DNA synthesis. [22] Electron microscopy studies have revealed that the morphology of SHG cells is different compared to the bulge: SHG cells possess much higher cytoplasmic density and fewer desmosomes (Figure 2A -C; [14] ). The increase in cytoplasmic density of epithelial cells is usually linked to a higher metabolic activity, organelle content (EPR cisterna and Golgi saccules) or to neoplastic transformation [eg [23, 24] ]. Concomitantly, a reduction of desmosome number is favourable for increase in cell motility. [25] All these specific morphological features fit the designation of late telogen SHG cells as "activated" or "primed" [14, 26] as compared to the bulge. Nevertheless, the nature and functional meaning of this "priming" (ie presetting for proliferation and further differentiation) remain unclear and require further elucidation (see Section 6 below).
To be designated as a distinct anatomical entity, a cellular structure should be morphologically distinguishable from the neighbouring tissues, encompass particular type(s) of cells and possess certain specific functions. The SHG in mouse pelage follicle meets all these criteria, and therefore, is certainly a distinct structural component of the telogen HF. But what is the adaptive/functional rationale for the formation of this structure? Why do two distinct cell populations with hair regrowth ability (the bulge and the SHG) exist right next to each other in the mouse telogen HF? Surprisingly, this question has been addressed directly only once. [27] It was suggested that the SHG as a population of "primed stem cells" is set apart to protect bulge cells ("a reserve stem cell population") from excessive proliferation and associated risk of mutagenesis thus enhancing bulge cell longevity. In support of this proposition, the authors invoked the facts of progenitor compartment duality in the intestine and bone marrow.
[27]2
While this suggestion certainly has its reasons, we assume that the appearance of the SHG as a separate morphological entity is primarily driven by two specific features of the mouse HF-its small size and periodic, nearly instant regrowth, highly synchronized with neighbouring follicles. What is the rationale behind this assumption?
As it is evident now, the intercellular paracrine signalling plays a pivotal role in the maintenance of HF functional homeostasis, especially in its stem/progenitor cell compartments [eg [28] [29] [30] ]. Therefore, the physical distance between the cells fulfilling different functions is of critical importance. Given that the telogen mouse HF is quite 2 Nevertheless, the "primed" cell subpopulations in these tissues never form such morphologically distinct structures as the SHG in the lower mouse HF during telogen.
F I G U R E 4 Schematic drawing representing early stages of anagen progression (based on the analysis of time-laps in vivo imaging data obtained using K14H2BGFP mouse line and multiphoton laser scanning [3, 21] Figure 2F ; [32] Figure 2F )-just two-three dozens of cells, [31] it is tempting to suggest that two of its major cell populations (the bulge and the SHG) are set apart not (or not only) to avoid the risk of mutagenesis in the bulge, but rather to avoid paracrine cross-influence between these two cell populations and to sustain an appropriate "signalling environment" inside each of them-a stem/quiescence milieu in the bulge and a pro-morphogenic setting in the SHG. It should be noted that the human terminal scalp HF, which is of much bigger size, does not seem to have a morphologically distinct SHG (see Section 7 below).
Another potential cause for SHG formation in mouse telogen follicles may be linked to the necessity for their speedy, nearly instant and highly synchronized regrowth, especially during the first two hair cycles. Setting apart a population of cells with specific sensitivity to anagen-inducing paracrine signalling, as well as with highly predetermined morphogenetic potential, is a most efficient way to achieve both goals: the isolated situation of SHG cells makes them all equally and easily accessible targets for delicate variations in inductive signal intensity and facilitates their presetting for an instant and highly coordinated execution of a specific morphogenetic programme. At the same time, SHG partition helps to protect the bulge stem cell niche from all these activities and from FP-derived signalling. Taking it all together, we consider the formation of a SHG as an essential prerequisite of highly synchronized cycling of murine pelage follicles.
| The SHG is characterized by a set of specific protein markers not expressed in the bulge
In addition to morphology, the distinctiveness of a functional cellular structure is based on a unique gene expression profile. Thus, identification of SHG-specific markers is critically important for precise demarcation of this structure. Furthermore, it is also essential for [65] Outer bulge. Human bulge is CD34-negative [60] Garza et al [39] Nfatc1 + − Horsley et al [66] Greco et al [14] Shirokova et al [13] S100A4 + − Ito et al [20] Also present in FP Slc1a3 + − Sada et al [147] Inner bulge in telogen. IRS in anagen.
K6 + − Sada et al [147] Inner bulge.
Markers, positive in the SHG and negative (low) in the bulge P-cad − + Müller-Röver et al [32] Mostly in lower SHG.
Dnmt1
− + Li et al [40] P16 − + Li et al [40] Foxi3 − + Shirokova et al [13] Most prominent at the SHG-FP border.
Gsdma3
− + Bai et al [148] hr − + Panteleyev et al [149] mRNA (in situ hybridization). Protein was not detected.
Gata6
− + Wang et al [154] Whether Gata6 is expressed in telogen SHG [154] or only in early anagen SHG progeny [31] remains to be clarified. Also a marker of sebaceous duct lineage. [153] Runx1 low + Osorio et al [48] In SHG and in the lower portion of the bulge.
Bmpr1a low + Botchkarev et al [47] In SHG and in the lower portion of the bulge.
Markers, that are expressed in both the bulge and the SHG CD200 + + Garza et al [39] Not expressed in the human telogen bulge.
Basonuclin + + Weiner & Green [150] ΔNp63 + + Romano et al [151] K14 + + Sada et al [147] Outer bulge and SHG (is missing in inner bulge).
Lgr5
+ low Jaks et al [102] Bulge contains both, Lgr5-and Lgr5 + cells. Diminished in SHG.
Greco et al [14] Sox9 + low Greco et al [14] Diminished in SHG.
K15 + +/− Lorz et al [52] In the bulge and upper SHG. Is missing or diminished in lower SHG (in cells adjacent to FP).
better understanding of SHG functions and, importantly, for specific molecular targeting of SHG progeny using novel genetic approaches (eg for cell fate/lineage tracing). One of the first proteins found to be differentially expressed in the mouse bulge and SHG was p-cadherin, [32] a cell adhesion molecule which is still the most widely used SHG marker ( Figure 2F ). Previously, it was reported that during mouse embryogenesis, P-cad expression is associated with segregation of specific cell groups in different tissues and organs. [33] In the skin, P-cad is implicated in segregation of epidermal and HF keratinocytes and formation of a functionally distinct subpopulation of highly proliferative hair matrix germinative cells adjacent to the FP. [32, 34, 35] Furthermore, P-cadherin maintains human HFs in anagen through the activation of canonical Wnt signalling and expression of the anagen-promoting growth factor IGF-1. [36] 4 It was also shown that the CDH3 gene, which codes for P-cad, is a direct target of p63, a master regulator of developmental processes in the skin. [37] It is important to note here that all cell populations in prenatal skin, which become P-cad positive, are not only highly proliferative, but are also actively involved in morphogenetic processes. Interestingly, Ber-EP4, an antibody demarcating another cell adhesion protein EpCAM, [38] also shows specific positivity at the bottom of the human telogen follicle ( Figure 5B ), in the cells, which may bear similarity to the mouse SHG [10, 39] (see also Section 7) . Therefore, it is tempting to propose that SHGspecific features and commitments are linked to the acquisition of new adhesive properties, which not only drive segregation of SHG cells and keep them together, but also determine their morphogenetic potential.
Another protein, which is highly expressed in the SHG and allows to distinguish it from the bulge by immunofluorescence, is DNA (cytosine-5)-methyltransferase 1-Dnmt1. [40] It is one of the key factors controlling global methylation-driven epigenetic shifts during mammalian development. [41] Targeted suppression of Dnmt1 in mouse skin using the K14-Cre recombination approach results in the decline of sensitivity to anagen-inducing signals, including plucking, leaving most Dnmt1-KO follicles in telogen. [40] It was suggested that K15-positive stem cells in the bulge of these mutant follicles have a reduced ability to become activated. Nevertheless, given the apparent lack of bulge abnormalities in Dnmt1-KO follicles and exclusive localization of Dnmt1 in the telogen SHG, but not the bulge, [40] we assume that the causative reason for hair phenotype in these mice is localized in the SHG cells rather than in the bulge.
The same study [40] has identified p16 (Ink4a), an alternatively spliced variant of the Cdkn2a gene product, as a protein highly expressed in the telogen SHG and not present in the bulge. P16 orchestrates the cell cycle exit by blocking the G1 to S phase transition. [42, 43] Its activity restrains the proliferation of islet cells [44] and of basal epidermal keratinocytes. [43] These features make p16 an attractive candidate for restraining cell proliferation in the SHG, especially at the terminal (or "competent" [45] ) phase of telogen, when SHG cells show obvious signs of activation [14] (see also Supplementary text S2). The proposed restraining role of p16 in the SHG cell activity is reminiscent of the BMP pathway, which holds back the onset of anagen through suppression of Wnt and Shh signalling. [46] It should be also noted that Bmpr1a, a receptor for Bmp2 and Bmp4, is also highly expressed in the SHG during the telogen and is instantly shut down upon telogenanagen transition. Bmpr1a is expressed in the bulge as well, but its expression there is much lower (as compared to the SHG) and is concentrated mostly in the lower bulge zone neighbouring the SHG. [47] Another protein marker of the telogen SHG is Runx1 (runtrelated transcription factor 1, a member of the polycomb protein group). The patterns of its expression [48] [49] [50] are similar to Bmpr1a:
Runx1 is also expressed in the bulge, but to a much lower extent as compared to the SHG and mostly in the lower bulge part. This limited Runx1 positivity in the bulge sometimes leads to misdesignation of this protein as a specific bulge marker (eg [51] ), while its localization in the SHG is certainly much more characteristic. Runx1 is involved in the maintenance of stem cell populations in different tissues. [52] In the HF, it controls telogen-to-anagen transition through activation of Wnt and Lef1 signalling [48] and, possibly, through downregulation of CDK inhibitor p21. [53] Of interest, Runx1 is significantly upregulated in the SHG and proximal bulge segment in the telogen HFs of aged mice as compared to young mice. Surprisingly, the expression of its downstream negative target p21 is also increased in aged telogen follicles [50] making the role of Runx1/p21 interactions in anagen induction quite obscure. See also Supplementary text S3.
Most recently, Foxi3, a transcription factor of the forkhead family and a target of ectodysplasin A (Eda) pathway in hair placodes, [54] was identified as a specific marker of the telogen SHG. [13] Foxi3-deficiency in mice, generated using K14-driven Cre recombination, results in abrogation of HF anagen downgrowth and impediment of the hair cycle. Gene expression profiling of embryonic skin in these mice has revealed downregulation of a number of targets expressed concurrently in both the bulge and the SHG of the telogen HF, for example Sox9, Lhx2 and K15 (Table 1 ; Figure 2E ). Downregulation of markers differentially labelling these two HF cell populations (Runx1 and hr for the SHG and Nfatc1 for the bulge) was also observed. [13] Given the exclusive expression of Foxi3 in the SHG of the telogen follicles, downregulation of bulge-specific Nfatc1 suggests a possibility of SHG influence upon bulge cells. In any case, the significant number of bulge-and SHG-specific genes among Foxi3 targets, as well as the severe hair phenotype in Foxi3-deficient mice 3 The "specificity" of molecular markers is certainly a relative issue. Most biological processes are regulated by signalling gradients, and therefore, the expression of potential markers should be discussed in terms of "more/less" rater then "present/absent." Given the semi-quantitative nature of immunohistochemistry, making the list of reliable SHG protein markers is a challenging task. 4 Also of interest, while P-cad is crucial for HF development in humans, it does not appear to be essential for this process in mice, [36, 37] suggesting that P-cad may play different roles in mouse and human HFs.
and Foxi3-mutant dog breeds, [55] designate Foxi3 as a potential master regulator of SHG and bulge specificity, with a high position in the hierarchy of HF progenitor cell regulatory milieu (see also
Supplementary text S4).
Altogether, the data on specific expression of several key regulatory proteins in the SHG highlight its functional difference from neighbouring cell populations in the telogen HF, primarily from the bulge. However, for most markers mentioned above, two questions require special attention: 1) are these markers expressed homogenously through the SHG (ie are all SHG cells the same) 5 and 2) how does their expression change during the catagen-telogen-anagen transition (ie how expression of these markers is linked to SHG formation and "predetermination")? The list of SHG-specific protein markers will indeed be expanding, providing further insight into the functions of this HF structure, but these two questions will always be of particular significance.
| Protein markers, which are negative in the SHG and positive in the bulge
To better understand the functional difference between SHG and bulge cells, it is important to pinpoint not only the positive SHG markers, but also the proteins specific to the bulge and not expressed in the SHG. Thorough analysis of existing immunofluorescence data on about a dozen of proteins, commonly designated as "bulge markers," has revealed that so far only CD34 and Nfatc1 can be reliably used to differentiate the bulge from the SHG in mouse
HFs. This is in line with the previous conclusions. [14] Out of the two, CD34 is most commonly used as a marker of mouse bulge cells and is suitable for both immunofluorescence ( Figure 2D ) and cell sorting.
It is important to note that in human HFs, the bulge is CD34-negative. [56,57]6 CD34 is a cell surface glycoprotein of the sialomucin group with still poorly defined functions, which is characteristic of undifferentiated multipotent cells usually designated as "stem" or "progenitor" cells. It was proposed that CD34 functions might be linked to both growth signalling (mediated by growth factor receptors) and, at the same time, to adhesive signalling (mediated by cell adhesion receptors such as integrins). [61] CD34 controls stem cell attachment to the extracellular matrix [62] and stem cell trafficking by suppressing cell-cell adhesion and enhancing migration. [63] In mouse HFs, CD34 is specifically localized in the outer layer of the bulge region (harbouring a pool of HF stem cells; [64] ) during all stages of the HF cycle and never appears in the SHG. [65] Furthermore, CD34 positivity in the bulge does not spread into the expanding SHG cell progeny during early anagen. [3] Assuming 5 The first ever attempt to answer this question has been recently undertaken.
[26]
6 Interestingly, CD34 is also a specific marker of mouse mast cells, [58] but human mast cells are CD34-negative, [59] similarly to the human bulge.
[60]
F I G U R E 5 Human HF (adopted with permission from: A and C -Lyle et al., 1998 [137] ; B -Garza et al., 2011 [39] ; D-F -Oh et al., 2016 [16] ; G -Commo et al, 2000 [112] ; H -courtesy of Dr. Bruno 
(G) (H') (H)
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the negative role of CD34 in cell adhesion, the absence of this marker in the SHG looks to be in line with the high level of SHG positivity for adhesion markers such as P-cad.
Nfatc1, another bulge marker not expressed in the SHG, [66, 67] is a transcription factor that plays an important role in osteoclastogenesis and in heart semilunar valve formation in mice. [68] Interestingly, Nfatc1 activity in both valve primordia and human HF cultured in vitro is negatively regulated by cyclosporin A, [67, 69] which, in turn, stimulates HF growth/hypertrichosis [70, 71] and even drives HF restoration in nu/nu mice. [72] The Foxn1 gene (the causative factor of nude mutation) regulates the expression of hair keratin genes [73] and thus, the nu/nu phenotype is certainly associated with the defects in internal (ascending) layers of the anagen HF. [74] The ability of cyclosporin A (also inhibiting Nfatc1 in mouse skin [66] )
to reverse the nu/nu phenotype suggests that Nfatc1 may have inhibitory effects specifically upon the ascending layers of the HF.
Taking all that into account, it is tempting to speculate that Nfatc1 may restrain the activated bulge cells from slipping into the process of cell fate specification along the SHG-like (hair-forming) lineage thus obliterating their morphogenetic potential and supporting their stem-like phenotype.
Altogether, the data on SHG cell morphology and the list of positive/negative SHG protein markers suggest three main features of SHG cells that make them different from the bulge: 1) "activated" phenotype (which, nevertheless, is restrained by proliferation blockers such as p16 or Bmpr1a); 2) specific cell-cell adhesion properties (P-cad); and 3) specific epigenetic profile (Dnmt1, hr). The list of proteins implicated in control of these SHG features remains to be extended. Modern technologies, for example, comparative chromatin profiling [75, 76] or single-cell RNA-sequencing, [26] offer effective tools for further endeavour into SHG-bulge functional and expressional partitioning.
| DOE S THE S HG HARBOUR A S TEM CELL P OPUL ATION?
Despite the fact that the gene expression portrait of SHG cells is relatively well defined, the functional nature of these cells remains unclear. It is widely accepted now that the SHG is not a part of the stem cell-containing bulge, nevertheless, the view of the SHG as a "stem cell population" is still quite common. Sometimes the SHG is also identified as a population of "transit-amplifying cells" or just as a part of "stem cell niche," suggesting that SHG cells themselves are not stem cells per se, but play a role in the maintenance of bulge cell stemness, as inner bulge cells do. [1] Furthermore, in some publications, these designations are used concurrently, thus producing a great deal of ambiguity. All in all, the currently prevailing view is that during telogen, the HF stem cell pool is composed of two compartments-the bulge and the SHG. [9, 14, 18, 31, 77] Consequently, the SHG is simply considered as a "second stem cell population" [eg [13] ] or, more specifically, as a population of "primed stem cells". [14, 27, 78] At the same time, the functional rationale for the existence of two stem cell populations next to each other is usually not discussed (see sec- 
| The expression of conventional stem cell markers is lacking or diminished in SHG cells
It was shown by microarray profiling (mRNA level) and immunofluorescence (protein level; Even though it was convincingly shown that Sox9 expression is much lower in SHG cells as compared to the bulge, [14] some authors still continue to designate this stem cell marker as a specific tag for both, quoting the original study by Nowak and co-authors. [79] In fact, Nowak and co-authors never reported Sox9 localization in the SHG, since they only assessed the expression of this protein in the hair placode and primary HG during HF morphogenesis and did not look at the secondary HG in the telogen follicle. [79] In this light, such misuse of terminology can be rather detrimental.
Using microarray profiling, E. Fuchs' research group has also demonstrated that Sfrp1 (secreted frizzled-related protein) is among the most downregulated genes in the SHG (-73x), as compared to the bulge. [14] Sfrp1 is a Hedgehog target which restrains canonical Wnt signalling in stem or progenitor cells. [80] It is noteworthy that another general Wnt inhibitor, Dkk4, is among the primary negative targets of Foxi3, which is specifically expressed in the SHG and not found in the bulge. [13] Presumptive deficiency of Wnt-inhibiting activity in the telogen SHG may provide further evidence that this HF cell population does not fit the classical gene expression signature of "stemness" (see also Supplementary text S6).
Another pair of stem cell-specific genes, dramatically downregulated in the SHG at the mRNA level as compared to the bulge, [14] are Fgf18 and Bmp6 (-239x and -37x, respectively). Both of them | 709 PANTELEYEV are quiescence-supporting factors, produced by bulge stem cells. [81] Fgf18 controls the length of bulge cell quiescence, and its conditional knock out significantly shortens the telogen in mice, thus promoting a strikingly rapid succession of hair cycles. [82] The lack of Fgf18 expression in the telogen SHG can be, by itself, an anagen-triggering feature. Nevertheless, despite Fgf18 downregulation in the SHG, the telogen phase in mouse skin can last for months after the completion of catagen and formation of the SHG. It is tempting to suggest that the "anagen-promoting" Fgf18 deficiency in the SHG is functionally compensated during telogen through elevated expression of proliferation suppressors such as p16/Ink4a. [40] P16 slows down the G1 to S phase transition through inhibition of cyclin-dependent kinases CDK4 and CDK6, [83] and hence can potentially keep SHG cells in a "ready-to-go" yet silent state even under Fgf18 deficiency. If so, timely suppression of p16 in the SHG may serve as a releasing factor for anagen onset (see also Supplementary text S2).
Altogether, current expression data show that many specific markers of the HF bulge stem cells are missing or significantly diminished in the SHG.
| Conventional stem cell features are not characteristic of SHG cells
Although the gene expression profile can be suggestive, it is not sufficient to identify cells of a given type as "stem" or "not stem" cell population. Stemness is certainly a functional phenomenon, and, therefore, evaluation of the "stemness" of SHG cells should be based first and foremost on their functional features.
So far, only one assessment of SHG cell clonogenicity has been attempted. [14] SHG cells were isolated using the P-cad vs CD34 fluorescence-activated cell sorting procedure. After 3 days in culture, P-cad(+):CD34(-) cells (presumably "SHG type") yielded 17x more colonies that were also much bigger in size as compared to "bulge type" cells. At the same time, bulge cells retained the ability to form colonies over 9 passages, while SHG cells failed to grow beyond passage 3 to 4. Thus, SHG cells are able to produce larger colonies at faster rate, but exhaust this capacity after a relatively small number of passages. These findings suggest that bulge cells possess much higher clonogenicity, while the SHG might simply "be endowed with the ability to initiate the burst of cell proliferation". [14] This experiment, however, was performed in vitro, in cell culture conditions designed for human epidermal keratinocytes, [64, 84] not for mouse HF keratinocytes, and it is not known how SHG-and bulge-derived cells would behave in a culture medium specifically supporting the SHG phenotype. Unfortunately, such a medium (a putative combination of SHG-specific growth factors, ECM components, supporting cells,
is not yet available.
The proliferative potential of the SHG cells revealed by the discussed clonogenicity assessment [14] is reminiscent of transit-amplifying (TA) cell characteristics and seems to be in line with the occasional designation of SHG cells or their immediate progeny (during telogen-anagen transition) as a TA cell population [eg [26, 78] ].
This designation, though, does not seem to be valid due to several reasons. Firstly, the above-mentioned results [14] were obtained in cell culture conditions supporting cell proliferation, but lacking instructive signals and positional context. During anagen induction in vivo, in a normal regulatory setting, the SHG-derived cells are instantly recruited into the morphogenetic process, [3] suggestive of their pre-anagen commitment to certain differentiation fates. This "predetermined" morphogenetic potential of SHG cells, as well as their prolonged telogen quiescence, does not fit into the commonly accepted designation of TA cells as "non-committed proliferating cells". [85] Traditionally, TA cells are also considered as non-motile and non-invasive. [86] That also does not apply to immediate SHG cell progeny which is highly motile. [3] Furthermore, the classical concept of TA cells suggests that they have a short lifespan, [27] while mouse SHG cells (especially in older animals with a longer telogen) can persist for months. Finally, we assume that the TA concept in its original definition [87] applies to the interfollicular epidermis and may not be relevant to the SHG at all.
Self-renewal is a key feature of stemness, which maintains the volume and undifferentiated state of a stem cell population over its lifetime. [88] In line with this assertion, bulge cells are self-renewing during the anagen stage of the hair cycle. [31] The self-renewing capacity of SHG cells remains indeterminate. [89] Given the transitional nature of the SHG, we assume that the phenomenon of self-renewal is not applicable to the SHG cell population. At any rate, there is no evidence of cell division in the SHG before its activation during telogen-anagen transition [14] and no evidence that any SHG (P-cad
cells are left behind (close to the bulge) after anagen induction (see
Supplementary text S7).
Another customary (but not undisputable) stem cell feature is the potency to differentiate along multiple lineages. The bulge cells have been shown to be multipotent. [90] In contrast, under normal conditions, the cells of the lower SHG only produce matrix cells. bulge has only been shown for depilation-induced HF regrowth, [9] when severe damage (and hence, a massive burst of cytokine release) evokes dramatic reprogramming of all remaining cells. In a less destructive (more accurate), and thus more "physiologic," elimination of telogen bulge cells by a laser beam, the bulge is replenished by the cells located higher up in the isthmus of the follicle but not by the SHG. [3] All of these facts suggest that the SHG cells (especially cells in its lower part) are highly predetermined to a single fate-the "hair matrix." Overcoming this predetermination requires severe exogenous damage such as depilation, which probably evokes dedifferentiation of SHG cells. [153] The activity of SHG cells is highly dependent on FP-derived signalling. We assume that the FP may also control SHG cell fate determination. Given the limited potency of SHG cells, it is tempting to speculate that the FP not only controls the ability of SHG cells [90] [91] [92] [93] [94] [95] ]. SHG cells seem to lack these potentials, but the final verdict on their relative "potency" can only be given based on in vivo assessment using a mouse reporter line with SHG-specific promoter. To date, no such studies have been performed. The potency of SHG cells in an ex vivo context has never been tested either.
The above data suggest that most of the conventional stem is so often disregarded. We suggest that the designation of SHG cells as a "germinative" [8] (meaning "having the power to produce a definite organ") or a "founder" [96] cell population would be more appropriate.
| THE S HG CELL S ARE S PECIFI C ALLY DE S TINED TO PRODUCE A SCEND ING L AYER S OF THE ANAG EN HAIR FOLLI CLE
A compelling line of recent evidence supports the old (but longunderappreciated) proposition that anagen HF regrowth starts in the SHG. [5] The The live visualization of HF cells using the K14H2BGFP mouse line and multiphoton laser scanning [3, 21] allows for detailed anal- cytes. [98] This specific layer of SHG-derived cells is astonishingly similar to the structure forming at the tip of the archenteron invagination during gastrulation in the sea urchin embryo, [99] suggesting similar morphogenetic implications. This basal layer of Lef1/pSMAD2-positive keratinocytes [26, 78] certainly represents a "primitive matrix population", [100] which is a precursor to the germinative layer in the hair matrix during advanced anagen. [35] It is noteworthy that this germinative layer ( Figure 2G and 4B)
is also highly P-cad positive, [32] similarly to the telogen SHG ( Figure 2F ,H), which this layer is originating from. The nature of these cells as well as mechanisms driving their specification and maintaining their long-lasting multi-lineage potential is among the most intriguing, yet unresolved issues in hair biology which has just begun to unveil. [26] The next stage of anagen progression, as evident from live timelapse recordings, [3] is associated with a dramatic reorganization of the internal structure of the growing HF primordium: an inverted V-shaped notch appears in its central part splitting the immediate SHG progeny into two cell subpopulations: the lower (onionshaped), which is actively proliferating, and the upper, which is still much less dynamic ( Figure 4B-C) . Then, this notch elongates vertically (along with the downward growth of hair peg), and a layer of regularly arranged cells is formed on its internal edge, 7 demarcating a gap between the future ascending HF layers (inside and below of the notch) and the progeny of the upper SHG part (outside of the notch), which still proliferate much less actively ( Figure 4C ). At this stage (corresponding to anagen II-III), the lower bulge cells also begin to proliferate ( Figure 4C-D) , but still do not initiate any noticeable downward cell migration [3] and cease proliferation by anagen IV. [78] This interim lower bulge activation, paralleled by an increase in Brg1 expression, [101] is driven by Shh signalling, emanating from the immediate SHG progeny [78] but not from the FP, as it was previously assumed.
With further anagen progression, the cells located below and inside of the initial notch (the progeny of the lower SHG) turn into the growing, as we call it, "hair cone"-a specific funnel-shaped structure (future complex of inner root sheath layers), which lines the hair canal and accommodates the ascending hair shaft. At the same time, the cells from the upper (outer) side of the notch (ie originating from the upper portion of the SHG progeny) remain randomly organized, but increase their proliferation intensity and eventually form the ORS ( Figure 4D ).
The above scenario of SHG cell fate ( Figure 6C ), based on live imaging of early anagen HFs, [3] is supported by more recent data from the same group. [21] This later study demonstrates that the majority of bulge cells stay quiescent and do not participate in HF regrowth at all or are lost during anagen progression. Only a minor fraction of bulge cells (not more than 18%) contribute to the subsequent hair cycle, aiding in the formation of the relatively undifferentiated ORS during advanced anagen stages. This fraction of bulge cells contributing to the ORS most likely represents a Lgr5+/Akt-phosphorylated (ie "activated") subpopulation of bulge cells described previously [102, 103] and located in the lower part of the bulge. The activation of these cells relies upon SHH produced by expanding SGH progeny (not by cutaneous sensory nerves) in Anagen II-III, [78] thus further confirming primary role of SHG in anagen induction.
While lower bulge cells do contribute to the ORS, the primary source of ORS is certainly represented by the cells of the upper SHG. This conclusion is confirmed by the known ability of the SHG to produce the entire HF (including the ORS) without any contribution from the bulge cells even under normal circumstances, not associated with any kind of stress or damage. [21] It should be noted that the cells from the lower part of the SHG were never seen in the ORS and were exclusively destined to generate the HF matrix and ascending layers of the new HF. [3] Altogether, the analysis of existing data on the fate of SHG cells during early anagen leads to a number of conclusions:
1. The telogen SHG (its lower portion) possesses three highly predetermined features: specific responsiveness to anagen-inducing signals, the ability to expand instantly and an exceptional morphogenetic potential, which although is strictly limited to the formation of a highly specialized structure-the ascending part of the HF (hair shaft and inner root sheath complex).
2.
These potentials of telogen SHG cells are ready to be deployed, but are held back by a number of "restraining factors" (p16, BMPs, etc.). These factors may be intrinsic or can emanate from the FP or other nearby tissues, including the inner (K6+) bulge.
[78]8
In any case, a compelling line of evidence supports the view that 7 We assume that these cells may represent a keratin 79-positive population of migratory epithelial cells that drives formation of hair canal during both HF morphogenesis and early anagen regrowth. [12, 100] 8 If so, depilation of hair shaft in telogen and consequent loss of inner bulge may trigger anagen induction through SHG activation.
F I G U R E 6 The scheme, depicting different views on signalling flow and cell kinetics during HF cycle progression (red dashed box demarcates structures implicated in anagen initiation).
A, The bulge activation hypothesis [6] is purely bulge-centric. It suggests a key role of FP-bulge interactions in anagen induction and direct bulge contribution to formation of all HF layers. The SHG is considered just as a transitional cell population between the bulge and the hair matrix. B, The most common current view admits a higher role of the SHG in anagen induction and progression. However, the bulge is still seen as a master regulator of cellular dynamics in the HF during catagen-telogen-anagen transition being in direct signalling contact with the FP and contributing immensely to the SHG formation and anagen HF regrowth (to both ascending layers and the ORS). The SHG is usually considered as a second (provisional) stem cell population in the telogen HF. C, The scenario proposed in this review (modified hypothesis of HF predetermination [8] ). As denoted by the position of red dashed box, the SHG is considered as the only target of FP signalling and as a major source of HF regrowth in early anagen, that is, formation of both, ascending layers (from the lower SHG cells) and the ORS (from the upper SHG). The bulge (especially its upper portion) appears to remain quiescent serving just as a reserve stem cell population. During more advanced anagen stages, some lower bulge cells are activated contributing to the ORS (this contribution is much less significant than assumed before) and, possibly, to the hair matrix. Lower bulge may be activated by signals from upper SHG. In late catagen, a new SHG is formed from both, the ORS remnants (lower SHG) and directly from the bulge (upper SHG) [22] ] would be detrimental to the proper maintenance of the bulge stem cell niche. Therefore, the SHG in mouse HFs serves as a screen, protecting the bulge from paracrine FP signalling.
3.
The primary role of the SHG is to fuel the HF regrowth (anagen) and to generate a specific morphogenetic setting or "environment," essential for an effective formation of the HF structure and production of the hair shaft (ie a germinative zone at the bottom of the hair matrix; Figure 2G and 4B-D). This SHGmaintained regulatory setting (both expressional and positional) during telogen-anagen transition draws parallels to the concept of the morphogenetic field [99, 104] in its modern interpretation as a regulatory phenomenon, positioned between the transcriptome and the resulting 3D morphological structure. [105, 106] 4. Upon anagen induction, the cells of the immediate SHG progeny promptly diverge into two functional portions-the upper one with slow rates of proliferation and ORS fate, and the lower one, which is exclusively destined to form the matrix and ascending HF structures ( Figure 4A-C) . This observation is in line with most recent identification of two basal progenitor subpopulations in the early anagen (Ana-II) mouse follicles. [26] As revealed by single-cell expressional analysis, one of these subpopulations displayed certain characteristics of ORS, while another one expressed companion layer markers (Krt79, Krt6a) and a number of transcription factors identifying these cells as precursors of the matrix germinative layer. [26] We believe that these two expressionally distinct cell subpopulations in early anagen HF correspond to the upper and lower portions of the immediate SHG progeny.
Whether this functional and expressional duality is preset due to different origin of upper and lower SHG cells (see section 5 on SHG origin) or is established during telogen, remains to be clarified. It is noteworthy that starting from early telogen, P-cad expression is specifically confined to the lower part of the SHG ( Figure 2F ). P-cad is also expressed in epithelial strand cells during the late catagen and in the germinative layer of the HF matrix during anagen. [32] These observations support the former option (early specification of the upper and lower SHG parts due to their different origin) and suggest that there is a link between P-cad activity and SHG/hair matrix cell fate. Furthermore, sequential transfer of P-cad positivity between potentially consanguineous HF cell populations (lower SHG-matrix-epithelial strand-lower SHG) over a succession of hair cycles may be an evidence of the "hair cycle continuity" proposed earlier. [8] 5. In the early anagen, the ORS is formed by the immediate progeny of the upper SHG with occasional contribution from the bulge ( Figure 6C ). Therefore, the bulge is not the main source of the ORS as was previously proposed. [8, 78] The dual origin of the ORS cells (from the upper SHG and lower bulge) is in line with the data suggesting a polyclonal origin of this HF structure [35] (see also
Supplementary text S8).
6. The role of the bulge in HF regrowth appears to be much less significant than previously assumed (compare Figure 6A,C) . The upper bulge cells remain fully uncommitted, while the lower bulge is subject to partial activation 9 -a minor fraction of lower bulge cells proliferates during anagen II-IV, [66, 78] contributing to the ORS. [21] In advanced anagen, these bulge-derived ORS cells may further contribute to the germinative layer of the hair matrix.
Nevertheless, the majority of slow-cycling bulge cells (marked by pulse-chase with H2BGFP) stay quiescent during the telogen-anagen transition and the entire anagen phase of the cycle. [93] We assume that these dormant bulge cells correspond to the CD34+/ Lgr5-population of reserve stem cells. [103] 7. In the telogen HF, several mechanisms (including the formation of is purely morphogenetic by nature and is fuelled by the immediate progeny of the lower SHG part. This subphase of the cycle was previously described for a human HF and designated as "neogen", [107] but the term M-anagen ("morphogenetic" anagen) seems to be more appropriate. The completion of matrix cell specification (possibly coinciding with the exhaustion of SHG-derived progenitors and the beginning of ORS-derived cells melding into the matrix) demarcates the transition from the "morphogenetic" to the "hair producing" subphase of anagen (anagen III-VI) which we designate as P-anagen ("productive" anagen). This second subphase is morphogenetically inactive and is characterized by simple "secretion" of a keratinized hair shaft (see also Supplementary text S9).
| THE ORI G IN OF S HG CELL S
The question of SHG cells origin during the catagen-telogen transition is not a trivial one, since the answer may shed light on the phenomenon of morphogenetic predetermination of these cells, which we consider to be one of the key issues in hair biology. 9 This activation certainly depends on lower SHG progeny and not on FP. [78] Currently, two main views on the SHG origin exist. The prevailing view considers SHG as a direct descendant of bulge cells migrating downward during the catagen-telogen transition. [9, 108, 109] The alternative view suggests that the SHG originates from the catagensurviving cells of the ORS moving upward, [8] thus designating the SHG as a "remnant" of the lower (cycling) HF part, and therefore, an indirect descendant of the bulge, given that at least some of the ORS cells originate from the bulge (see above).
To date, only a few attempts, specifically focusing on the origin of the SHG, have been undertaken. Two of them [9, 14] have utilized label-retaining cell methodology (see Supplementary text S10), and the third one [21] -genetic lineage tracing.
In fact, a bromodeoxyuridine (BrdU) pulse/chase approach [9, 14] is insufficient to prove or disprove either scenario of SHG formation.
This approach has obvious limitations as a lineage tracing method. [110, 111] BrdU positivity of two cells is suggestive but not conclusive of their common origin. Thus, the controversy of SHG origin can be resolved only through a study fulfilling three major requirements: the use of a reporter mouse line with specific targeting of bulge cells (eg using CD34 promoter), the study of the natural (not depilation-induced) HF cycle with focus on catagen-telogen transition, and, finally, the use of a live imaging approach to directly confirm cell movement from one location to another. A recent study by V. Greco's research team fulfilled these requirements. hair germ". [21] Thus, at least a part of SHG originates from the cells of lower (cycling) HF portion. Nevertheless, these apoptosis-resistant bulge-derived cells were scattered over the ORS [21] and were not organized into any kind of structure, reminiscent of the "lateral disc"
( Figure S1A ) as was proposed by the HF predetermination hypothesis. [8] Furthermore, in genetically engineered mice, where the LacZ reporter was driven by the lateral disc-specific Shh promoter, the SHG revealed no β-gal positivity. [13] Thus, the proposition that SHG precursor cells may originate from the compact cell population such as the "lateral disc" in the HF bulb [8] was basically disproved. 10 At the same time, the idea that some bulge-derived progenitor cells may be maintained in a specific ORS niche, as was proposed for the human HF( [8, 112] ; Figure S1B ), still remains a possibility. Tcf4 positivity in a trail of lower ORS cells [113] may demarcate this putative cell population.
Thus, the cells from the cycling HF portion (originating from the previous hair cycle) are certainly present in the telogen SHG, as it was previously proposed. [8] Furthermore, it was shown that these cells directly originate from the middle ORS [1] and their number in the SHG is dependent on bulge contribution to the ORS during the previous anagen. [78] Therefore, the telogen SHG cells, at least in part, are indirect (through the ORS) descendants of the bulge, recruited from the previous hair cycle. How can these findings be reconciled with the data supporting a direct origin of the SHG from the bulge during the catagen-telogen transition [eg [9] ]? We assume that such reconciliation is possible on the ground of SHG heterogeneity, which becomes apparent through in vivo visualization of cell motility in the early anagen, [3] as well as through differential gene [26] and protein (eg P-cad; [32] ) expression in the telogen SHG cells. Presumably, after anagen initiation. [26] Both of these populations robustly expressed cell cycle-related genes. Nevertheless, one of them showed similarity with the ORS, while the other expressed companion layer markers and a number of regulatory factors, linking them to the progenitor cell phenotype. [26] The relation of these two expressional cohorts to the upper and lower SHG progeny ( Figure 4B -C) remains to be confirmed.
The prompt functional split of SHG cells upon anagen induction can only be explained by the preexistence of SHG cell heterogeneity already in telogen, which, in turn, may be linked to the SHG originating from two different sources. We propose that the cells of the upper SHG originate directly from the bulge during the catagentelogen transition in accordance with Ito's model, [9] while the cells in the lower SHG are formed by the cells descending from the middle ORS/epithelial strand, which survive catagen. [8, 78] This view of SHG duality ( Figure 6C ) is supported by H2BGFP pulse-chase experiments, which demonstrate that bulge-derived label-retaining cells appear in the SHG of the telogen HFs, but exclusively in its upper, P-cad negative portion, neighbouring the bulge ( Figure 2H ) and are never seen in the lower SHG. [14] 11 Concurrently, the cells of the catagen epithelial strand are positive for P-cad-a marker of lower SHG cells, [32] thus supporting the ontogenetic connection of the lower SHG with the cycling HF part.
Most recently, using FACS purification and single-cell RNAsequencing of 71 telogen SHG cells, three expressionally distinct SHG subpopulations (HG1-3) have been identified. [26] This spatial heterogeneity of telogen SHD cells (from the SHG/bulge downward to the SHG/FP border) was assumed to be primarily driven by 10 Nevertheless, the "lateral disc," as we call it, [8] certainly exists as a defined cell population in the hair matrix of the anagen mouse HF. The origin and functions of this cell cluster remain unknown.
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It was shown that during early telogen, the SHG increases in size without any sign of proliferation, thus suggesting immigration of cells from the bulge. [31] This process is driven, at least in part, by Runx1. [48, 49, 53] gradual changes in BMP responsiveness. The HG1 subpopulation bears some similarities with the bulge cells (supporting their ontogenetic relation), while the HG3 signature is similar to the subpopulation of immediate SHG progeny, responsible for the formation of the hair matrix germinative layer. HG3 cells were specifically characterized by an enrichment of genes related to translational regulation, the mTOR pathway and the TCA cycle, as well as by appearance of nuclear LEF1, reflecting WNT signalling activation and inhibition of the BMP pathway. [26] We assume that HG1 and HG3 signatures identified by Yang and co-authors represent the cells of the upper and lower (closest to FP) SHG subpopulations, respectively. HG2, while representing a distinct expressional cohort, is closer to HG3 [26] and may constitute companion layer precursors.
Altogether, based on the existing data, we propose that the 
| THE PRIMING (PREDE TERMINATION) OF S HG CELL S
The predetermination of SHG cells to a specific fate (formation of a new HF) implies three major aspects: 1) a selective sensitivity to anagen-inducing signals that emanate from the FP [18, 114] or other sources like sensory nerves or subcutaneous fat [115, 116] ; 2) an exceptional proliferative potential, which, nevertheless, is held back by a number of restraining mechanisms maintaining the telogen SHG in a standby state; and 3) a strong morphogenetic commitment to produce the ascending compartment of the anagen HF through formation of the hair matrix ("germinative layer" [35] ).
The first aspect of SHG predetermination (selective sensitivity to anagen-inducing signalling) can be viewed as a potentiation of downstream effectors of the WNT, FGF and TGFb2 pathways, as well as BMP inhibitors, which all are known to induce the telogenanagen transition. [14, 45, 47, [117] [118] [119] Shh signalling seems not to play any significant role in this process, rather representing a bulge-specific activation pathway [78] (see also Supplementary text S11). Even though the list of molecular players involved in the potentiation of SHG sensitivity to anagen-inducing signals is already substantial (for review see [29, 82, 120] ), the hierarchy of these factors and, importantly, the exact spatiotemporal pattern of their activity in late telogen remain to be clarified. The current view suggests that the prelude to anagen is characterized by the elevation of SHG cells' sensitivity to WNT-mediated gene activation, associated with the rise of Lef1/ Tcf1 levels. This localized increase in sensitivity to WNT signalling is reflected in the appearance of nuclear β-catenin in pre-anagen SHG cells while the nuclei of the bulge cells remain negative (cytoplasmic β-catenin positivity is seen in both the bulge and the SHG). It was proposed that these effects are linked to the establishment of Tcf3/ Tcf4-low and Lef1/Tcf1-high SHG cell expression phenotype during the late telogen and the telogen-anagen transition. [121] In general, the intrinsic activation of the WNT pathway in the SHG and the eventual stabilization of β-catenin towards the end of telogen appear to be critical for HFs sensitization to anagen induction. [14, 119, 122, 123] These changes in late telogen SHG are paralleled by the increase in Fgf7/10 ligands and the decrease in Fgf18 and Bmp levels. [120] The second aspect of SHG predetermination is reflected in its ability to undergo an instant burst of proliferation.
Given the "restraining" nature of the SHG regulatory milieu during telogen, especially during its "competent" stage (see section 2 on page 17), the induction of SHG cells proliferation should be driven by "blocking the blockers." The mechanisms implicated in the initiation and support of SHG cell growth during early anagen are extensively studied and include, among others, the EGF, [124] IGF1, [125] WNT, [26, 122] TGF-β1, [126] TNF-a, [127] HGF, [128] Stat3, [154] Gata6, [155] and, possibly, Shh [78] regulatory pathways. As shown by comparative gene expression profiling of the early and late telogen SHG cells, most of these pathways become activated during the late telogen stage in concert with the accumulation of proliferationmaintaining proteins. [14, 26] Furthermore, in late telogen, the stilldormant SHG appears to be a site of active DNA synthesis. [129] While it is difficult to envision a physiological meaning of this effect, 12 it certainly indicates that late telogen SHG cells possess a high level of metabolic activity and are quite different from the truly quiescent early telogen SHG cells not only expressionally, [14] but functionally as well.
It should be noted that the transition of the early telogen SHG cells to the succeeding still-quiescent, yet potentiated state ("late" or "competent" telogen [14, 45] ), has multiple similarities with the transition of a plant shoot apical meristem from an "off-line" dormant state to the so-called "standby" quiescent (but induction-responsive) state during the process of seed vernalization which, presumably, is driven by chromatin remodelling. [130] The third aspect of SHG predetermination (morphogenetic commitment) is not as well defined, as its commitment to activation and growth. The morphogenetic processes are initiated in the immediate SHG progeny right after anagen induction, suggesting that a specific developmental programme is preset in the SHG cells before anagen onset. Hence, in the late telogen, SHG cells are not only in a standby 12 For possible interpretation, see. [120] proliferative state, but also possess a strong morphogenetic commitment to form a complex miniorgan, the HF, comprising a number of specialized structures (HF layers), each with its own proliferation rate and differentiation programme. The sonic hedgehog (Shh) pathway seems to be implicated in the maintenance and/or in realization of this potential. Shh morphogen is one of the earliest functionally relevant markers of lineage-committed cells and its expression is robustly induced in immediate SHG progeny concomitant with matrix specification. [26, 78] It was also shown that the application of monoclonal antibodies 5E1, which specifically neutralize Shh, results in the eventual failure of HF formation. [131] After 5E1 treatment, the mouse telogen HFs (SHG cells, as we assume) retain their ability to respond to anagen-inducing signals by proliferation, but fail to undergo morphogenetic specification and to proceed into the anagen III stage. [100] Nevertheless, Shh pathway is activated in SHG progeny at Anagen II stage only and Shh protein is absent in the SHG at either telogen or anagen I stage of the cycle, [26] suggesting that Shh activity is not implicated in the process of acquisition of the morphogenetic potential by SHG cells.
Currently, the nature of the morphogenetic "presetting" of SHG cells, the time point when this "presetting" is acquired, and the mechanisms maintaining the balance between the "inductive" and "instructive" [132] potentials of the SHG cells remain poorly understood.
So far, it is only certain that all these features are predetermined by active reciprocal signalling between the SHG cells and their microenvironment [eg [26, [133] [134] [135] ]. The proximity of the upper SHG to the bulge and of the lower SHG to the FP may be a causative factor for the positional diversity of SHG cells and the significant differences in morphogenetic potentials between these two SHG cell subpopulations. Alternatively (or concurrently), these differences may arise from the different origin of the upper and lower SHG cells-from the bulge and the catagen epithelial strand, respectively. Recently, expressional diversity of telogen SHG was confirmed at the single-cell level [26] (see also Section 5 above).
All in all, the three aspects of SHG cell predetermination highlight the vital role of this process in anagen induction, HF regrowth and maintenance of steady HF cycling. Previously, through the analysis of regenerative waves in the hair coat of aged mice, it was revealed that scattered telogen zones on the mouse back can be either "refractory" or "competent," reflecting their inability or ability to respond to anagen-inducing signals. [45] We assume that the functional competency of telogen follicles, as it is seen by M. Plikus and co-authors, [45] is certainly a SHGlinked phenomenon and is not associated with the bulge. The acquisition of competency is specifically linked to the transition of the early telogen SHG to the "pre-anagen" state, thus reconciling the "refractory" and "competent" states of telogen follicles [45] with the "early" and "late" telogen gene expression profiles of the SHG cells, [14] respectively. See also Supplementary text S12.
Furthermore, we consider the process of the gradual transition of SHG cells from the refractory to the competent telogen subphase as an essential component of the process of their "predetermination," as was put forth earlier by the corresponding hypothesis. [8] See also Supplementary text S13.
| IS THE S HG PRE S ENT IN H UMAN TELOG EN FOLLI CLE S?
Strict association of the SHG with the telogen stage of the HF cycle hinders the identification of this structure in human skin. In contrast with mouse pelage follicles, human HFs cycle asynchronously, have long anagen (lasting up to several years) and very short telogen phases. Thus, only a minor fraction of human scalp follicles is usually in telogen-from 1 up to 15% of the total [eg [16, 136] [eg [39] ] Nevertheless, it is widely accepted that the SHG does exist in human telogen follicles, has the same fate and fulfils the same functions as it does in mouse skin [eg [16] ] Is there a factual basis for such a viewpoint?
In contrast with the mouse telogen pelage follicles, which are nearly identical in size and form, the shape of the human scalp follicles at the "resting" phase of the cycle is quite variable. Their lower part (the zone of the presumptive location of the SHG) is usually irregular in shape with multiple protrusions [eg, [39, 137] ] resembling "bulges" or "SHGs". 13 The FP may be associated with either of these protrusions, not necessarily at the HF bottom ( Figure 5A ). Even if the shape of the lower human telogen follicle is relatively regular, its rounded bottom (which is massive compared to mouse HF) usually does not have a well defined, spatially distinct structure, which can be identified as a SHG based on morphological features, 14 as it is in a mouse telogen HF.
The data suggesting the presence of an expressionally distinct cell population at the bottom of the human telogen HFs are also lacking. Gene expression profiling of cells isolated from human telogen follicles (flow cytometry and quantitative real-time PCR) revealed a substantial cellular diversity of the lower HF part, but none of the identified expressional subpopulations was morphologically segregated similarly to mouse SHG. Furthermore, none of these subpopulations matched the mouse SHG in their gene expression signature. [39] 13 In old publications, human bulge (in both anagen and telogen) is often described (and depicted) as a multilobular structure (eg [138] ); see also Figure 5A .
Expression of protein markers specific to the mouse SHG (ie P-cad, Runx1, Foxi3, p16/Ink4a, Dnmt1) was, to our knowledge, never assessed in human telogen follicles by immunohistochemistry. At the same time, the expression of Ber-EP4 (the only protein marker with specific localization at the very bottom of the human telogen HF and presumably demarcating a SHG-like structure [10, 39] ) was never assessed in mouse telogen skin. Thus, neither morphological, nor existing expressional data provide a sufficient ground for drawing parallels between the mouse and the putative human SHGs.
Furthermore, if a morphological entity similar to mouse SHG does exist in the human telogen follicle (eg Figure 5B-C) , it may play no role in anagen induction, serving just as a mechanical structure, as a stalk that keeps FP away from the bulge and, at the same time, holds FP "on a leash" (the loss of HF-FP connection would be detrimental for hair cycle progression, as it is evident from hairless phenotype in mice and humans [139] ). 15 So far, no "regulatory markers" have been credibly identified in the zone of putative human "SHG," in striking contrast to mouse SHG specifically expressing such regulatory proteins as Foxi3, p16/Ink4a and Dnmt1 (Ber-EP4 positivity, localized to the putative human "SHG," identifies an adhesion proteinEpCAM [38] ). Unfortunately, the morphological ambiguity of "human may just not be necessary in the human telogen follicle. Second, the human scalp HFs cycle at a very slow rate and in a random pattern (not synchronously). They are tailored to produce a hair shaft of undefined length over a long period of time. 16 This is in stark contrast to the mouse HFs, which are destined to produce several generations of hair shafts of fixed length on a highly patterned and tight time schedule. Consequently, the process of telogen-anagen transition is much less time-limited in human HF as compared to mouse follicle. Thus, the different follicle size and pace of cycling may be at the core of all major functional differences between mouse and human HFs. We assume that this also applies to SHG segregation, which just may not be advantageous in human terminal telogen follicles. At the same time, it should be taken into account that different types of human HFs differ significantly in size. The anagen vellus follicles, which are present in the scalp of human adults in a proportion of 4%-40%, [140, 141] are much smaller compared to the terminal scalp hairs-1:2 in diameter, 1:6 in length and 1:2.7 in the length of the bulge. [142] Whether there is any difference in morphology between telogen vellus and telogen terminal scalp hairs remains to be determined. We believe that human vellus HFs in telogen may be comparable to mouse telogen follicles in size and thus may function in a similar way and form a SHG-like structure. 17 It is important to point out that keratin 19 has a very different spatial pattern of expression in vellus and terminal human follicles, [143] further suggesting a significant functional difference between these two types of human HFs. Thus, the classical model of direct bulge stem cell involvement in anagen initiation [6] may still be valid for human HF. In any case, both options for anagen source (bulge stem cell or scattered SHG-like cells) are in line with the significant differences in the early anagen progenitor cell kinetics between mouse [eg [1, 3] ] and human HFs. [112, 144] The different relevance of SHG paradigm to human and mouse HFs is further supported by dissimilar outcomes of P-cad deficiency in HFs of these species: while P-cad activity is crucial for HF development in human skin, [37] it does not appear to be essential for this process in mice. [36, 145] Given that this protein is a key marker of SHG in mouse HFs, it casts further doubts on SHG analogy in mouse and human skin. The situation with the SHG may mirror the drastic human/mouse differences in another HF structural part-the bulge.
While in mouse HF, the bulge is morphologically, functionally and 15 If this is the case, this structure in human telogen follicle should be designated as "follicular stalk" not as a "hair germ." 16 The cycling does not seem to be essential for human HFs, and, in fact, may represent an atavism. 17 One of very few images showing the human HF not only in a perfect telogen phase but also with a regular rounded bottom adjoined by a structure reminiscent of the mouse SHG and differing expressionally from other HF parts ( Figure 5B ; adopted from [39] ) seems to represent a vellus HF. 18 As was mentioned before, the bottom part of the human telogen HF certainly bears cells with different gene expression profiles, but none of these cell subpopulations matches the mouse SHG in terms of its gene expression signature or clusters together to form a distinct morphological entity. [39] expressionally distinct from the rest of the follicle, in human terminal HF, the bulge is not apparent and may be not existing as such. [146] All things considered, the data available so far are not sufficient to draw a definite conclusion about the presence of SHG in human 
| CON CLUS IONS
The bulge activation hypothesis [6] -the first comprehensive concept In this review, we attempted to refine the current views on the basic aspects of SHG functioning including the origin of this structure and its role in two key aspects of mouse HF biology-anagen induction and formation of such a complex and functionally robust miniorgan as the HF is ( Figure 6C) . The data acquired during the last decade, especially the input from E. Fuchs' and V. Greco's laboratories [eg, [3, 14, 21, 26] ], provide a compelling line of evidence supporting the primary role of the SHG, but not of the bulge, in both of these pro- The origin of the SHG cells, their features and functions, all contradict their placement into the "stem cell" category. Being highly predetermined for rapid execution of a specific morphogenetic scenario, they should rather be designated as a "germinative" or a "founder" cell population. The mechanisms driving this predetermination and transition of SHG cells from the "refractory" to the "competent" state during the telogen stage of the HF cycle remain to be elucidated. For that to be realized, the following steps may be of help: 1) gene expression profiling of the presumptive SHG cell subpopulations (upper and lower parts) at defined time points of HF transition from catagen through telogen to anagen 20 ; 2) search for new SHG protein markers, especially ones specific to the upper and lower SHG parts; 3) designing a cell culture medium specifically 19 The HFs in sheep and guinea pigs are of much bigger size (as compared to mouse HFs) and cycle asynchronously, in a mosaic pattern, similar to that in human HFs. Therefore, the skin of these two species may represent a better model for deeper endeavour into human HF biology, including its telogen stage and the SHG controversy. Development of an effective in vitro or grafting (eg human HF on mouse recipient) models allowing to explore the catagen-telogen and telogen-anagen transitions of the human HFs in experimental setting would be another option. 20 The first study addressing this issue has been recently published. 26 supporting the SHG cell phenotype; and 4) development of mouse reporter lines selectively targeting the SHG (ie using P-cad, Dnmt1
or Foxi3 promoters).
The specific features of the mouse SHG, especially its tendency for "predetermination," make this HF structure an attractive model that could be instrumental to address a number of fundamental bi- techniques, however, the HF will take its rightful place in the toolbox of science.
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